Cell loss and class distribution of TH-I cells in the substantia nigra of the neurological mutant, weaver

1990 ◽  
Vol 510 (2) ◽  
pp. 242-250 ◽  
Author(s):  
M.W. Smith ◽  
T.R. Cooper ◽  
T.H. Joh ◽  
D.E. Smith
1996 ◽  
Vol 738 (1) ◽  
pp. 172-175 ◽  
Author(s):  
Patricia K Sonsalla ◽  
Nina D Jochnowitz ◽  
Gail D Zeevalk ◽  
Jo A Oostveen ◽  
Edward D Hall
Keyword(s):  

1997 ◽  
Vol 773 (1-2) ◽  
pp. 223-226 ◽  
Author(s):  
P.K Sonsalla ◽  
L Manzino ◽  
C.M Sinton ◽  
C.-L Liang ◽  
D.C German ◽  
...  

2019 ◽  
Vol 28 (4) ◽  
pp. 379-387
Author(s):  
Scott C. Vermilyea ◽  
Scott Guthrie ◽  
Iliana Hernandez ◽  
Viktorya Bondarenko ◽  
Marina E. Emborg

α-Synuclein (α-syn) is a small presynaptic protein distributed ubiquitously in the central and peripheral nervous system. In normal conditions, α-syn is found in soluble form, while in Parkinson’s disease (PD) it may phosphorylate, aggregate, and combine with other proteins to form Lewy bodies. The purpose of this study was to evaluate, in nonhuman primates, whether α-syn expression is affected by age and neurotoxin challenge. Young adult ( n = 5, 5–10 years old) and aged ( n = 4, 23–25 years old) rhesus monkeys received a single unilateral carotid artery injection of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Three months post-MPTP the animals were necropsied by transcardiac perfusion, and their brains extracted and processed with immunohistochemical methods. Quantification of tyrosine hydroxylase (TH)-positive substantia nigra (SN) neurons showed a significant 80–89% decrease in the side ipsilateral to MPTP administration in young and old animals. Optical density of TH- immunoreactivity (-ir) in the caudate and putamen presented a 60–70% loss compared with the contralateral side. α-Syn-ir was present in both ipsi- and contra- lateral MPTP-treated nigra, caudate, and putamen, mostly in fibers; its intracellular distribution was not affected by age. Comparison of α-syn-ir between MPTP-treated young and aged monkeys revealed significantly higher optical density for both the ipsi- and contralateral caudate and SN in the aged animals. TH and α-syn immunofluorescence confirmed the loss of nigral TH-ir dopaminergic neurons in the MPTP-treated side of intoxicated animals, but bilateral α-syn expression. Colabeling of GAD67 and α-syn immunofluorescence showed that α-syn expression was present mainly in GABAergic fibers. Our results demonstrate that, 3 months post unilateral intracarotid artery infusion of MPTP, α-syn expression in the SN is largely present in GABAergic fibers, regardless of age. Bilateral increase of α-syn expression in SN fibers of aged, compared with young rhesus monkeys, suggests that α-syn-ir may increase with age, but not after neurotoxin-induced dopaminergic nigral cell loss.


2002 ◽  
Vol 28 (4) ◽  
pp. 283-291 ◽  
Author(s):  
C. R. Cabello ◽  
J. J. Thune ◽  
H. Pakkenberg ◽  
B. Pakkenberg
Keyword(s):  

2022 ◽  
Author(s):  
Min Hyung Seo ◽  
Sujung Yeo

Abstract Parkinson’s disease (PD) is known as the second most common neurodegenerative disease, which is caused by destruction of dopaminergic neurons in the substantia nigra (SN) of the brain; however, the reason for the death of dopaminergic neurons remains unclear. An increase in α-synuclein (α-syn) is considered an important factor in the pathogenesis of PD. In the current study, we investigated the association between PD and serine/arginine-rich protein specific kinase 3 (Srpk3) in MPTP-induced parkinsonism mice model and in SH-SY5Y cells treated with MPP+. Srpk3 expression was significantly downregulated, while tyrosine hydroxylase (TH) decreased and α-synuclein (α-syn) increased after 4 weeks of MPTP intoxication treatment. Dopaminergic cell reduction and α-syn increase were demonstrated by inhibiting Srpk3 expression by siRNA in SH-SY5Y cells. Moreover, a decrease in Srpk3 expression upon siRNA treatment promoted dopaminergic cell reduction and α-syn increase in SH-SY5Y cells treated with MPP+. These results suggest that the decrease in Srpk3 expression due to Srpk3 siRNA caused both a decrease in TH and an increase in α-syn. This raises new possibilities for studying how Srpk3 controls dopaminergic cells and α-syn expression, which may be related to the pathogenesis of PD. Our results provide an avenue for understanding the role of Srpk3 during dopaminergic cell loss and α-syn increase in the SN. Furthermore, this study could support a therapeutic possibility for PD in that the maintenance of Srpk3 expression inhibited dopaminergic cell reduction.


2000 ◽  
Vol 871 (2) ◽  
pp. 259-270 ◽  
Author(s):  
Dennis C Harvey ◽  
Goran Lacan ◽  
Simon P Tanious ◽  
William P Melega
Keyword(s):  

2002 ◽  
Vol 13 (5) ◽  
pp. 605-612 ◽  
Author(s):  
Ronald L. Klein ◽  
Michael A. King ◽  
Mary E. Hamby ◽  
Edwin M. Meyer

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Masayoshi Kano ◽  
Masashi Takanashi ◽  
Genko Oyama ◽  
Asako Yoritaka ◽  
Taku Hatano ◽  
...  

AbstractParkin (encoded by PRKN) is a ubiquitin ligase that plays an important role in cellular mitochondrial quality control. Mutations in PRKN cause selective dopaminergic cell loss in the substantia nigra and are presumed to induce a decrease in mitochondrial function caused by the defective clearance of mitochondria. Several studies have demonstrated that parkin dysfunction causes mitochondrial injury and astrocytic dysfunction. Using immunohistochemical methods, we analyzed astrocytic changes in human brains from individuals with PRKN mutations. Few glial fibrillary acidic protein- and vimentin-positive astrocytes were observed in the substantia nigra in PRKN-mutated subjects compared with subjects with idiopathic Parkinson’s disease. We also differentiated patient-specific induced pluripotent stem cells into midbrain organoids and confirmed decreased numbers of glial fibrillary acidic protein-positive astrocytes in PRKN-mutated organoids compared with age- and sex-matched controls. Our study reveals PRKN-mutation-induced astrocytic alteration and suggests the possibility of an astrocyte-related non-autonomous cell death mechanism for dopaminergic neurons in brains of PRKN-mutated patients.


Sign in / Sign up

Export Citation Format

Share Document